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Diabetic retinopathy is one of the most common causes of blindness in 24 
industrialized countries.1 It can lead to severe visual loss by causing retinal 25 
detachment, macular edema, vitreous hemorrhage, and neovascular glaucoma. 26 
Pars plana vitrectomy is known to be effective in preserving and restoring visual 27 
function in patients with proliferative diabetic retinopathy (PDR).2–6 Despite the 28 
large body of published material regarding the visual outcome of vitrectomy for 29 
PDR, the impact of this surgical intervention on patients’ quality of life (QOL) has 30 
not been reported in literature. 31 
In ophthalmology, traditional objective clinical outcome measures such as 32 
visual acuity are increasingly being complemented with assessment of patients’ 33 
perception of their visual function and quality of life. The National Eye Institute 34 
25-Item Visual Function Questionnaire (VFQ-25) is a vision-related QOL 35 
(VR-QOL) instrument designed to assess patients’ perception of their visual 36 
function and QOL.7 Prior studies have reported the influence of vitrectomy on 37 
VR-QOL in patients with macular hole,8–10 epiretinal membrane,11 and 38 
age-related macular degeneration.12,13 The purpose of this study was to evaluate 39 
the VR-QOL and visual function following vitrectomy for PDR by using VFQ-25. 40 
 41 
Methods 42 
We analyzed 51 eyes of 51 patients with PDR who were scheduled to 43 
undergo pars plana vitrectomy. Their age averaged 55.8 ± 12.1 years (mean ± 44 
SD), and there were 21 males and 30 females. Forty-six eyes of 46 age-matched 45 
subjects served as normal controls. The current study was a prospective, 46 
interventional, consecutive, comparative case series, and was conducted in 47 
accordance with the Declaration of Helsinki, and the study protocol was approved 48 
by the Institutional Review Committee of Tsukuba University Hospital. Prior to 49 
inclusion in the study, all patients provided written informed consent after the 50 
nature of the study was explained to them.  51 
The surgery was performed in our clinic by an experienced vitreoretinal 52 
surgeon from June 2005 through September 2006.  The indications for vitrectomy 53 
included recurrent or persistent nonclearing vitreous hemorrhage (11 eyes), 54 
traction or combined traction/rhegmatogenous retinal detachment (17 eyes), and 55 
adherent posterior hyaloid causing excessive macular traction (23 eyes). 56 
Exclusion criteria included patients with previous history of ocular surgery and 57 
ophthalmic disorders, except for mild refractive errors and mild cataract. Patients 58 
who had underwent vitrectomy for bilateral eyes within at least three months were 59 
also excluded. The presence and severity of cataract were graded using the lens 60 
opacities classification system III (LOCS III) reference standards.14 The following 61 
preoperative information was obtained for each patient: age, gender, duration of 62 
diabetes mellitus (DM), serum HbA1c, and fasting plasma glucose. Data on the 63 
patients’ characteristics are presented in Table 1.  64 
LogMAR best-corrected visual acuity (BCVA), letter contrast sensitivity, and 65 
the severity of metamorphopsia were obtained preoperatively and at 3 months 66 
postoperatively. Letter contrast sensitivity was measured using the CSV-1000LV 67 
chart (Vector Vision, Columbus, Ohio). Metamorphopsia was evaluated using 68 
M-CHARTS (Inami Co., Tokyo, Japan), which enable quantitative evaluation of 69 
the degree of metamorphopsia in patients with macular diseases.15,16 70 
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 71 
Surgical procedures 72 
All surgeries were performed by a single surgeon (F.O.) under sub-Tenon 73 
local anesthesia. The crystalline lens was removed by phacoemulsification and 74 
intraocular lens implantation when required, following by 20-gauge three-port 75 
pars plana vitrectomy. Using contact lenses, posterior hyaloid separation and 76 
removal of the posterior vitreous membrane were performed, and then bimanual 77 
delamination, en bloc dissection, and segmentation techniques were used to 78 
remove proliferative tissues. Membrane dissection and segmentation were 79 
performed when necessary to eliminate all tangential tractions. Peripheral 80 
vitrectomy and panretinal endophotocoagulation were routinely performed. 81 
Air-fluid exchange was performed when an iatrogenic retinal tear and/or 82 
rhegmatogenous retinal detachment were identified intraoperatively. 83 
 84 
Questionnaire (VFQ-25) 85 
The patients were requested to answer VFQ-25 preoperatively and 3 86 
months postoperatively to assess VR-QOL. Preoperative VFQ-25 was examined 87 
the day before or two days before operation. The research staff explained the 88 
questionnaire to the patients, verbally administered instruction, and provided 89 
assistance when required. The completed questionnaires were reviewed for 90 
missing data by the research staff. Prior to surgery, all the missing items were 91 
incorporated by the subjects themselves. 92 
The VFQ-25 comprises 25 items wherein patients are expected to assess the 93 
level of difficulty of particular visual symptoms or day-to-day activities. Each item 94 
is assigned to one of the 12 subscales, namely, general health, general vision, 95 
ocular pain, near activities, distance activities, social functioning, mental health, 96 
role difficulties, dependency, driving, color vision, and peripheral vision. The 97 
subscales are scored on a 0 to 100-point scale, where 100 indicates the highest 98 
possible function or the minimal subjective impairment. The VFQ-25 composite 99 
score is calculated as the unweighted average response to all items, excluding 100 
the questions regarding general health. 101 
The VFQ-25 used in this study was a Japanese version, with modifications 102 
to suit the Japanese culture and way of life. The modified NEI VFQ-25 103 
questionnaire has been assessed for reliability and validity, and it has been 104 
proven to accurately measure VR-QOL in Japanese individuals.17 105 
 106 
Statistical analysis 107 
The mean scores and standard deviations were calculated for each VFQ-25 108 
subscale result as well as for the VFQ-25 composite score in patients with PDR 109 
and normal controls. A Mann-Whitney U test was performed to compare each 110 
subscale score and composite score between the PDR patients and normal 111 
controls. The Wilcoxon signed-ranks test was used for variables that were 112 
present both pre- and  postoperatively. The relationships of the questionnaire 113 
scores with visual acuity, contrast sensitivity, metamorphopsia, age, duration of 114 
DM, serum HbA1c, and fasting plasma glucose were examined by the Spearman 115 
rank correlation test. To correlate visual acuity with the questionnaire score, the 116 
Snellen visual acuity was converted to its logMAR equivalent. Approximations for 117 
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visual acuity worse than 20/400 were as follows: counter fingers, 20/2000; hand 118 
motions, 20/4000; and light perception, 20/8000.18,19 All tests of association were 119 
considered statistically significant if P < 0.05. The analyses were carried out 120 
using StatView (version 5.0, SAS Inc., Cary, NC). 121 
 122 
Results 123 
The logMAR BCVA ranged from 2.30 to 0.00 preoperatively (mean, 1.24; 124 
median, 1.30) and from 2.60 to -0.08 postoperatively (mean, 0.46; median, 0.30). 125 
The vitrectomy significantly improved visual acuity (p < 0.0001), with 39 patients 126 
(75.0%) gaining 2 or more ETDRS lines. No change was observed in 9 eyes 127 
(17.3%), and vision decreased by 1 or more lines in 4 patients (7.6%). The 128 
postoperative reduction in visual acuity was attributed to neovascular glaucoma 129 
(2 patients) and optic disc atrophy (2 patients). These patients did not have 130 
neovasucular glaucoma and optic disc atrophy preoperatively. The mean letter 131 
contrast sensitivity significantly improved from 7.5 preoperatively to 15.0 132 
postoperatively (p < 0.001). 133 
 All patients underwent PDR surgery for their worse-seeing eye. The 134 
logMAR BCVA in the fellow eye ranged from 1.20 to 0.00 (mean, 0.62; median, 135 
0.60).  136 
Preoperative and postoperative mean logMAR BCVA on the type of PDR 137 
were vitreous hemorrhage (pre 1.34, post 0.25), tractional retinal detachment 138 
(pre 1.31, post 0.24), and excessive macular traction (pre 1.22, post 0.74). 139 
Further, preoperative and postoperative mean VFQ-25 composite scores on the 140 
type of PDR were vitreous hemorrhage (pre 51.2, post 62.3), tractional retinal 141 
detachment (pre 61.1, post 70.3), and excessive macular traction (pre 55.2, post 142 
59.4).  143 
        The results of VFQ-25 questionnaire pre- and postoperatively are shown in 144 
table 2. The preoperative VFQ-25 composite score was significantly lower in the 145 
PDR patients than in the normal controls (p < 0.0001). The preoperative 146 
subscales were significantly lower in the PDR patients than in the normal controls, 147 
except for ocular pain (p < 0.0001). Vitrectomy significantly improved VFQ-25 148 
composite score (p < 0.005) and subscales such as general vision, near activities, 149 
distance activities, social functioning, mental health, role difficulties, driving, and 150 
peripheral vision. However, postoperative VFQ-25 composite score still remained 151 
significantly lower in the PDR patients than in the normal controls (p < 0.0001). 152 
The preoperative VFQ-25 composite score exhibited significant correlation 153 
with the preoperative logMAR BCVA in the better-seeing eye but not in the 154 
worse-seeing eye (Figure 1). Significant correlation was also observed between 155 
the preoperative VFQ-25 composite score and letter contrast sensitivity (Figure 156 
1). The preoperative VFQ-25 composite score did not correlate with age (r = 157 
0.138, p = 0.496), duration of DM (r = 0.122, p = 0.523), serum HbA1c (r = 0.136, 158 
p = 0.400), and fasting plasma glucose (r = 0.051, p = 0.750). At 3 months 159 
postoperatively, the VFQ-25 composite score exhibited significant correlation 160 
with the logMAR BCVA in the worse-seeing eye as well as the better-seeing eye 161 
(Figure 2). Similar significant correlation was observed between the VFQ-25 162 
composite score and letter contrast sensitivity (Figure 2). However, there was no 163 
significant relationship between the postoperative VFQ-25 composite score and 164 
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the severity of metamorphopsia (r = -0.390, p = 0.081). Further, there was no 165 
significant correlation between changes in VFQ-25 composite score by surgery 166 
and changes in logMAR BCVA (r = -0.212, p = 0.148) and letter contrast 167 
sensitivity (r = 0.307, p = 0.093). 168 
 169 
Discussion 170 
In the present study, VFQ-25 composite score and all subscale scores, 171 
except for color vision, were significantly reduced in patients with PDR, indicating 172 
that those patients were suffering from a wide range of functional vision 173 
difficulties as compared to the normal controls. The preoperative VFQ-25 174 
composite score significantly correlated with visual acuity and contrast sensitivity 175 
in the better-seeing eye. Postoperatively, VFQ-25 composite score significantly 176 
correlated with the condition of the worse-seeing eye as well as the better-seeing 177 
eye. Previous studies reported that VR-QOL significantly improved following 178 
vitreous for age-related macular degeneration,12,13 macular hole,8–10 and 179 
epiretinal membrane peeling.11 The current study represents the first report that 180 
VR-QOL significantly improved following vitreous surgery for PDR. In patients 181 
with macular hole,8 4 of 12 subscales improved significantly with surgery, such as 182 
general vision, near activities, mental health, and role difficulties. Vitrectomy for 183 
epiretinal membrane significantly improved 2 of 12 subscales, including general 184 
vision and distance activities.11 Vitrectomy for PDR significantly improved 8 of 12 185 
subscales (general vision, near activities, distance activities, social functioning, 186 
mental health, role difficulties, driving, and peripheral vision) in this case series. 187 
Based on these previous and current findings, it is suggested that vitrectomy for 188 
PDR offers greater subjective improvement in VR-QOL than that for other 189 
macular disorders. 190 
The preoperative VFQ-25 composite score significantly correlated with 191 
preoperative visual acuity and contrast sensitivity in the better-seeing eye. These 192 
results are consistent with several previous reports. Miskala et al investigated 193 
VR-QOL in patients with subfoveal choroidal neovascularization by using the 194 
VFQ-25, and demonstrated that changes in the overall and subscale scores were 195 
linearly related to changes in visual acuity of the better-seeing eye but are not 196 
associated with changes in the worse-seeing eye.12 Deramo et al investigated 197 
VR-QOL in patients with unilateral central retinal vein occlusion and observed 198 
that VFQ-25 responses significantly correlated with visual acuity in the 199 
better-seeing eye.19 In other studies, VFQ-25 responses significantly correlated 200 
with binocular visual acuity in patients with macular hole and epiretinal 201 
membrane.8,11 In our study, VR-QOL was significantly associated with contrast 202 
sensitivity as well as visual acuity in the better-seeing eye. 203 
Interestingly, postoperative VFQ-25 composite score significantly correlated 204 
with postoperative visual acuity and contrast sensitivity in both the worse-seeing 205 
and better-seeing eyes. Until now, there has been no previous report that showed 206 
significant relationship between VR-QOL and visual function of the worse-seeing 207 
eye in patients with vitreoretinal diseases. In PDR, however, bilateral eyes are 208 
usually affected to a rather similar extent, while other vitreoretinal diseases such 209 
as macular hole and epiretinal membrane are generally unilateral. In our study, 210 
mean visual acuity in the better-seeing eye was considerably deteriorated (0.62 211 
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logMAR BCVA), and the difference between the better-seeing and worse-seeing 212 
eyes was small. This seems to be the reason why VFQ-25 score correlated with 213 
the visual function not only in the better-seeing eye but also in the worse-seeing 214 
eye.  215 
In several studies investigated quality of life outcomes following ocular 216 
surgery, only week or absent correlation between increase in quality of life and 217 
improvement of visual acuity was observed. 10,20 In this study, there was no 218 
significant correlation between changes in VFQ-25 composite score and changes 219 
in visual acuity. This finding suggests visual acuity is only one aspect of visual 220 
function, which explains why despite increased visual acuity and letter contrast 221 
sensitivity in several cases VFQ-25 values decrease in our series.  222 
There was no association between the severity of metamorphopsia and 223 
VFQ-25 composite score. This observation is consistent with the results of 224 
previous studies in patients with macular hole and epiretinal membrane.8,11 Thus, 225 
it seems that visual acuity and contrast sensitivity are more suitable indicators for 226 
patients’ VR-QOL than the degree of metamorphopsia. 227 
This study has certain limitations, including small sample size and 228 
short-term follow-up. The VFQ-25 score in patients with macular hole was more 229 
improved at 1 year postoperatively than at 3 months postoperatively.11 Thus, 230 
longer-term investigations of patients after vitrectomy for PDR might give 231 
somehow different results regarding VR-QOL and visual function. Future studies 232 
with a larger sample size and longer follow-up will further facilitate our 233 
understanding of the relation between VR-QOL and visual function in patients 234 
undergoing vitrectomy for PDR. 235 
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Figure legends 311 
 312 
Figure 1. Preoperative National Eye Institute 25-Item Visual Function 313 
Questionnaire (VFQ-25) composite score vs. preoperative logMAR 314 
best-corrected visual acuity (BCVA) and preoperative letter contrast sensitivity in 315 
patients with proliferative diabetic retinopathy.  316 
(Top left) VFQ-25 composite score vs. logMAR BCVA in the better-seeing eye: r = 317 
-0.446, p < 0.001. (Top right) VFQ-25 composite score vs. logMAR BCVA in the 318 
worse-seeing eye: r = -0.354, p = 0.072. (Bottom left) VFQ-25 composite score vs. 319 
letter contrast sensitivity in the better-seeing eye: r = 0.407, p = 0.016. (Bottom 320 
right) VFQ-25 composite score vs. letter contrast sensitivity in the worse-seeing 321 
eye: r = 0.255, p < 0.153. 322 
 323 
Figure 2. Postoperative National Eye Institute 25-Item Visual Function 324 
Questionnaire (VFQ-25) composite score vs. postoperative logMAR 325 
best-corrected visual acuity (BCVA) and postoperative letter contrast sensitivity in 326 
patients with proliferative diabetic retinopathy.  327 
(Top left) VFQ-25 composite score vs. logMAR BCVA in the better-seeing eye: r = 328 
–0.520, p < 0.0001. (Top right) VFQ-25 composite score vs. logMAR BCVA in the 329 
worse-seeing eye: r = –0.632, p < 0.0001. (Bottom left) VFQ-25 composite score 330 
vs. letter contrast sensitivity in the better-seeing eye: r = 0.323, p = 0.041. 331 
(Bottom right) VFQ-25 composite score vs. letter contrast sensitivity in the 332 
worse-seeing eye: r = 0.374, p = 0.014. 333 
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